Mutual Fund Details
NAV
₹24.3200
as on 03 Dec 2021, 11:15 PM
₹-0.1840(0.75%)
Last Change
Schemes Managed By
Start SIP in this Mutual Fund
Min SIP Amount
₹1,000
Suggested Date
10th of Every Month
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹2,21,230
₹2,32,213
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹1,32,213
Profit (absolute return)
132.21%
in the last
1m
3m
1y
3y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
3.86%
In the last 6 months
7.75%
In the last 1 year
29.40%
In the last 3 years
132.21%
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
Mirae Asset Healthcare Fund Direct-IDCW Payout
as of 31 Oct 2021, 05:30 AM
₹1,798.17 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 year.
0.56%
Expense Ratio
Plan
Dividend
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 year.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Oct 2021
Healthcare
89.28%
₹1,605.44 Cr
Chemicals
5.52%
₹99.28 Cr
Insurance
3.49%
₹62.80 Cr
Financial
1.15%
₹20.63 Cr
Diversified
0.77%
₹13.90 Cr
Cash Holding
-0.22%
₹-4.01 Cr
Companies Holding in this Mutual Fund
as on 31 Oct 2021
Sun Pharmaceutical Industries Ltd.
13.77%
₹247.61 Cr
Dr. Reddy's Laboratories Ltd.
9.10%
₹163.63 Cr
Divi's Laboratories Ltd.
8.90%
₹160.04 Cr
Apollo Hospitals Enterprise Ltd.
7.17%
₹128.93 Cr
Cipla Ltd.
7.04%
₹126.59 Cr
Torrent Pharmaceuticals Ltd.
5.52%
₹99.26 Cr
Ipca Laboratories Ltd.
4.01%
₹72.11 Cr
Lupin Ltd.
3.76%
₹67.61 Cr
Fortis Healthcare Ltd.
3.71%
₹66.71 Cr
Gland Pharma Ltd.
3.29%
₹59.16 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Oct 2021
Sun Pharmaceutical Industries Ltd.
13.77%
₹247.61 Cr
Dr. Reddy's Laboratories Ltd.
9.10%
₹163.63 Cr
Divi's Laboratories Ltd.
8.90%
₹160.04 Cr
Apollo Hospitals Enterprise Ltd.
7.17%
₹128.93 Cr
Cipla Ltd.
7.04%
₹126.59 Cr
Torrent Pharmaceuticals Ltd.
5.52%
₹99.26 Cr
Ipca Laboratories Ltd.
4.01%
₹72.11 Cr
Lupin Ltd.
3.76%
₹67.61 Cr
Fortis Healthcare Ltd.
3.71%
₹66.71 Cr
Gland Pharma Ltd.
3.29%
₹59.16 Cr
View All
View All
This fund's returns:
32.39%Return Duration
3 Years
DSP Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
23.74%
32.83%
3Y Returns
32.83
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹1000
Category Returns
23.74%
32.83%
3Y Returns
32.39
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
23.74%
32.83%
3Y Returns
27.49
Tata India Pharma & HealthCare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
23.74%
32.83%
3Y Returns
27.07
Nippon India Pharma Fund Direct-Growth
EquityPharma
Min. Investment
₹100
Category Returns
23.74%
32.83%
3Y Returns
26.33
About Mirae Asset Healthcare Fund Direct-IDCW Payout
Mirae Asset Healthcare Fund Direct-IDCW Payout is a Equity mutual fund scheme from Mirae Asset Mutual Fund. This scheme was launched on 02 Jul 2018 and is currently managed by its fund manager Vrijesh Kasera. It has an AUM of ₹1,798.17 Crores and the latest NAV decalared is ₹24.320 as on 05 Dec 2021 at 1:05 pm.
Mirae Asset Healthcare Fund Direct-IDCW Payout scheme return performance in last 1 year is 29.40%, in last 3 years is 132.21% and 141.75% since scheme launch. The min. SIP amount to invest in this scheme is ₹1000.
Scheme Details
| AUM: | ₹1,798.17 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 02 Jul 2018 |
| Fund Type: | Open-End |
Scheme Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
AMC Information
Mirae Asset Mutual Fund
View AMC Details
₹98,650.24 Cr
AUM
64
Schemes
Address
Unit No.606 - 6th Floor,Windsor Building - Off. CST Road,Kalina, Santacruz (East),400098
Phone Number
Phone : 022-67800301 / 1800-2090-777
Email / Website